Ensysce Biosciences Inc
General ticker "ENSC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $54.4M
Ensysce Biosciences Inc does not follow the US Stock Market performance with the rate: -33.7%.
Estimated limits based on current volatility of 11.3%: low 7.58$, high 9.52$
Factors to consider:
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.09$, 27.96$]
- 2024-12-30 to 2025-12-30 estimated range: [5.90$, 21.88$]
Financial Metrics affecting the ENSC estimates:
- Negative: Non-GAAP EPS, $ of -5.06 <= 0.10
- Negative: Operating profit margin, % of -82.77 <= 1.03
- Negative: Operating cash flow per share per price, % of -82.33 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ENSC quotes
Long-term ENSC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3.53MM | $2.52MM | $2.23MM |
| Operating Expenses | $23.40MM | $26.75MM | $12.95MM |
| Operating Income | $-19.87MM | $-24.22MM | $-10.72MM |
| Non-Operating Income | $-9.28MM | $0.01MM | $0.09MM |
| Interest Expense | $1.30MM | $0.11MM | $0.35MM |
| R&D Expense | $4.69MM | $19.84MM | $7.59MM |
| Income(Loss) | $-29.15MM | $-24.21MM | $-10.63MM |
| Taxes | $-0.00MM | $0.75MM | $-0.01MM |
| Profit(Loss) | $-29.15MM | $-24.96MM | $-10.61MM |
| Stockholders Equity | $-7.88MM | $-3.71MM | $-0.32MM |
| Inventory | $0.44MM | $0.28MM | $0.00MM |
| Assets | $16.42MM | $5.89MM | $2.71MM |
| Operating Cash Flow | $-8.24MM | $-17.89MM | $-10.78MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $20.31MM | $8.77MM | $8.76MM |
| Earnings Per Share* | $-346.90 | $-138.73 | $-4.69 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.